Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.60
+0.08 (0.94%)
Jun 12, 2026, 2:57 PM EDT - Market open

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $-29.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $65.50M, up 213.96% year-over-year. In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%.

Revenue (ttm)
$65.50M
Revenue Growth
+213.96%
P/S Ratio
21.94
Revenue / Employee
$178,460
Employees
367
Market Cap
1.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.40%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Ardelyx427.68M
Immunocore Holdings412.81M
UroGen Pharma140.49M
KalVista Pharmaceuticals114.48M
Septerna72.26M
Monte Rosa Therapeutics42.95M
Precigen31.60M
Revenue Rankings